Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.
about
In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerAnticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.Polymeric conjugates for drug deliverySynergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia.CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells.Tumor Targeting via Integrin Ligands.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Modifying the tumor microenvironment using nanoparticle therapeuticsComparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.RGDfK-functionalized gold nanorods bind only to activated platelets.Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells.
P2860
Q34674722-2A6ED5D4-832F-4ED4-A8B7-3E1E1B46639BQ34984769-159FA5A2-501B-44BD-9391-C8F7E01DFFDEQ35227265-6F574DF6-5A67-4C3D-A604-70F75AE084EEQ35375097-B5A840B2-1BBF-4DC8-8E45-FFB330E15785Q36029175-A9D56F14-33C2-4EA0-82C7-18DF5186899DQ37386314-7386ADE9-A3A6-4EB4-902F-21D48E32C8A7Q37588008-B6B76794-B84A-49D2-B17C-DDD78BF54EE7Q38134759-815F6E44-566E-4431-8BF3-3CC5BF338767Q38161395-735086A8-E164-44AD-B554-EB8B68F816BCQ38796320-A79AC90B-E40C-41D5-BF04-A19F1D8D80AEQ38991197-C1BA1537-467B-47C7-8305-202CE3041CD8Q39371541-72CE92DF-3E69-4A38-B4D2-E9B7A443295DQ39443391-D8C8F4B6-ACCC-4C92-A2F6-028D47456CBCQ39584202-C37034A0-1980-4CCB-AD35-21CC96429ECF
P2860
Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@ast
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@en
type
label
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@ast
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@en
prefLabel
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@ast
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@en
P2093
P2860
P356
P1476
Biodistribution of HPMA copoly ...... prostate cancer drug delivery.
@en
P2093
Edward A Sausville
Hamidreza Ghandehari
Mark P Borgman
Sandra Geyser-Stoops
P2860
P304
P356
10.1021/MP900134C
P407
P577
2009-11-01T00:00:00Z